Plus   Neg

Deutsche Post DHL Q2 Profit Climbs; Maintains FY20, FY22 Profit View

Deutsche Post DHL Group (DPSGY.PK) reported Wednesday that its second-quarter consolidated net profit climbed 14.6 percent to 525 million euros from 458 million euros last year. Earnings per share were 0.42 euro, up 16.7 percent from 0.36 euro a year ago.

Operating profit or EBIT grew 18.6 percent from last year to 912 million euros. Adjusted for non-recurring effects, EBIT climbed even by 229 million euros to 1.1 billion euros.

Group revenue increased 3.1 percent to 15.96 billion euros from last year's 15.48 billion euros in spite of Covid-19, benefited by its broad portfolio of logistics services and its global presence.

Both EBIT and revenues were slightly above the preliminary quarterly projections released in July.

Organic revenue growth, adjusted for portfolio and currency effects, was even higher at 4.6 percent, mainly driven by strong growth in e-commerce.

CEO Frank Appel said, "Especially now, our focus on our profitable core logistics businesses and the digital transformation of the company as part of Strategy 2025 pays off."

Further, for fiscal 2020, the company continues to expect operating profit to reach between 3.5 billion euros and 3.8 billion euros.

The company also maintained its fiscal 2022 outlook issued in July. Deutsche Post DHL expects Group EBIT of around 4.7 billion euros to more than 5.3 billion euros for 2022, depending on the shape of the general economic recovery.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Despite the coronavirus pandemic, retailers are prepared for an early start to the holiday shopping season by offering discounts earlier so that consumers can buy and receive the gifts they want in time, the National Retail Federation or NRF said. The NRF also said it is launching a nationwide consumer education campaign called "New Holiday Traditions". Facebook (FB) has revealed new messaging features for Instagram, which will make it easier for users to stay in touch with others across Facebook's family of apps. The main change is that people using the Messenger app can now reach Instagram users, and vice versa. The users can control where they receive... Regeneron Pharmaceuticals, Inc. announced positive first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 in COVID-19 patients. REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients. The company said it plans rapidly to discuss results with regulatory authorities.
Follow RTT